EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Doxorubicin, a DNA intercalator, inhibits transcription elongation

Mathew Tempel, Kari Green, Dhanvi Prajapati, Angela Duaqui, Mahboobeh Norouzi, Hedieh Sattarifard, Ahmed Ashraf, Elly Wu, Athanasios Zovoilis, Ted M Lakowski, James R Davie iD

Biochemistry and Cell Biology · 01.01.2025 · 103 · 1-12

DOI: 10.1139/bcb-2024-0264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry and Cell Biology, erschienen am 01.01.2025. Verfasst von Mathew Tempel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB …. Hauptthemen laut MEDLINE: Doxorubicin, Intercalating Agents, Transcription Elongation, Genetic, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, CancerCare Manitoba Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin is a chemotherapeutic drug for cancer that intercalates into nucleosome-free regions at promoters. Doxorubicin was reported to result in loss of histone H3 trimethylated lysine 4 (H3K4me3). To further explore doxorubicin’s mechanism of action, we determined the genomic location of the binding sites of doxorubicin in leukemic cells. The effect of doxorubicin intercalation into the chromatin of leukemic cells on histone modifications was also determined. We show that doxorubicin binding sites were present in the nucleosome-free regions associated with regulatory regions (promoters, enhancers, and super-enhancers) and in the gene body (introns). Doxorubicin treatment did not alter the levels of H3K4me3 and many other histone modifications but significantly lowered H2B ubiquitinated at lysine 120 (H2BK120ub), an elongation-dependent modification. Lastly, we demonstrate that doxorubicin results in the degradation of the largest subunit (RPB1) of RNA polymerase II.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinIntercalating AgentsTranscription Elongation, GeneticAntibiotics, AntineoplasticDNAHumansHistonesRNA Polymerase IIChromatin

Stichwörter der Autor:innen

H2B ubiquitinationRNA polymerase II degradationdoxorubicinelongationleukemia

Substanzen

DoxorubicinIntercalating AgentsHistonesRNA Polymerase IIAntibiotics, AntineoplasticDNAChromatin

Autor:innen und Institutionen

  • Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P4, Canada.
  • Department of Electrical and Computer Engineering, University of Manitoba, Winnipeg, MB R3T 5V6, Canada.
  • Paul Albrechtsen Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
  • Pharmaceutical Analysis Laboratory, College of Pharmacy, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.

ORCID-Profile: James R Davie

Förderung

  • Canadian Institutes of Health Research
  • CancerCare Manitoba Foundation

Zitieren

APA

Tempel, M., Green, K., Prajapati, D., Duaqui, A., Norouzi, M., Sattarifard, H., Ashraf, A., Wu, E., Zovoilis, A., Lakowski, T., & Davie, J. R. (2025). Doxorubicin, a DNA intercalator, inhibits transcription elongation. Biochemistry and Cell Biology, 103, 1-12. https://doi.org/10.1139/bcb-2024-0264

Vancouver

Tempel M, Green K, Prajapati D, Duaqui A, Norouzi M, Sattarifard H, et al. Doxorubicin, a DNA intercalator, inhibits transcription elongation. Biochemistry and Cell Biology. 2025;103:1-12. doi:10.1139/bcb-2024-0264

BibTeX
@article{Tempel2025,
  author = {Tempel, Mathew and Green, Kari and Prajapati, Dhanvi and Duaqui, Angela and Norouzi, Mahboobeh and Sattarifard, Hedieh and Ashraf, Ahmed and Wu, Elly and Zovoilis, Athanasios and Lakowski, Ted M and Davie, James R},
  title = {Doxorubicin, a DNA intercalator, inhibits transcription elongation},
  journal = {Biochemistry and Cell Biology},
  year = {2025},
  volume = {103},
  pages = {1--12},
  doi = {10.1139/bcb-2024-0264}
}
Kostenlos starten →